vs
Side-by-side financial comparison of CENTRAL PACIFIC FINANCIAL CORP (CPF) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
CENTRAL PACIFIC FINANCIAL CORP is the larger business by last-quarter revenue ($72.9M vs $47.7M, roughly 1.5× IRONWOOD PHARMACEUTICALS INC). CENTRAL PACIFIC FINANCIAL CORP runs the higher net margin — 28.4% vs -4.8%, a 33.2% gap on every dollar of revenue. On growth, CENTRAL PACIFIC FINANCIAL CORP posted the faster year-over-year revenue change (6.0% vs -47.3%). Over the past eight quarters, CENTRAL PACIFIC FINANCIAL CORP's revenue compounded faster (6.7% CAGR vs -20.2%).
Central Pacific Bank (CPB) is an American regional commercial bank located throughout the state of Hawaii.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
CPF vs IRWD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $72.9M | $47.7M |
| Net Profit | $20.7M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | — | 14.3% |
| Net Margin | 28.4% | -4.8% |
| Revenue YoY | 6.0% | -47.3% |
| Net Profit YoY | 16.7% | -200.9% |
| EPS (diluted) | $0.78 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $72.9M | — | ||
| Q4 25 | $76.3M | $47.7M | ||
| Q3 25 | $74.8M | $122.1M | ||
| Q2 25 | $72.8M | $85.2M | ||
| Q1 25 | $68.8M | $41.1M | ||
| Q4 24 | $58.4M | $90.5M | ||
| Q3 24 | $66.6M | $91.6M | ||
| Q2 24 | $64.0M | $94.4M |
| Q1 26 | $20.7M | — | ||
| Q4 25 | $22.9M | $-2.3M | ||
| Q3 25 | $18.6M | $40.1M | ||
| Q2 25 | $18.3M | $23.6M | ||
| Q1 25 | $17.8M | $-37.4M | ||
| Q4 24 | $11.3M | $2.3M | ||
| Q3 24 | $13.3M | $3.6M | ||
| Q2 24 | $15.8M | $-860.0K |
| Q1 26 | — | — | ||
| Q4 25 | 37.0% | 14.3% | ||
| Q3 25 | 31.6% | 61.8% | ||
| Q2 25 | 32.8% | 53.2% | ||
| Q1 25 | 32.8% | -70.7% | ||
| Q4 24 | 23.0% | 34.8% | ||
| Q3 24 | 25.6% | 28.0% | ||
| Q2 24 | 32.2% | 26.5% |
| Q1 26 | 28.4% | — | ||
| Q4 25 | 30.0% | -4.8% | ||
| Q3 25 | 24.8% | 32.8% | ||
| Q2 25 | 25.1% | 27.7% | ||
| Q1 25 | 25.8% | -90.9% | ||
| Q4 24 | 19.4% | 2.5% | ||
| Q3 24 | 20.0% | 4.0% | ||
| Q2 24 | 24.7% | -0.9% |
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.85 | $0.01 | ||
| Q3 25 | $0.69 | $0.23 | ||
| Q2 25 | $0.67 | $0.14 | ||
| Q1 25 | $0.65 | $-0.23 | ||
| Q4 24 | $0.42 | $0.03 | ||
| Q3 24 | $0.49 | $0.02 | ||
| Q2 24 | $0.58 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $215.5M |
| Total DebtLower is stronger | $76.5M | — |
| Stockholders' EquityBook value | $593.9M | $-261.8M |
| Total Assets | $7.5B | $396.9M |
| Debt / EquityLower = less leverage | 0.13× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | — | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | — | $105.5M |
| Q1 26 | $76.5M | — | ||
| Q4 25 | $76.5M | — | ||
| Q3 25 | $131.5M | $199.5M | ||
| Q2 25 | $131.5M | $199.3M | ||
| Q1 25 | $131.4M | $199.2M | ||
| Q4 24 | $156.3M | $199.0M | ||
| Q3 24 | $156.3M | $198.8M | ||
| Q2 24 | $156.2M | $198.6M |
| Q1 26 | $593.9M | — | ||
| Q4 25 | $592.6M | $-261.8M | ||
| Q3 25 | $588.1M | $-264.2M | ||
| Q2 25 | $568.9M | $-308.2M | ||
| Q1 25 | $557.4M | $-334.1M | ||
| Q4 24 | $538.4M | $-301.3M | ||
| Q3 24 | $543.7M | $-311.3M | ||
| Q2 24 | $518.6M | $-321.7M |
| Q1 26 | $7.5B | — | ||
| Q4 25 | $7.4B | $396.9M | ||
| Q3 25 | $7.4B | $396.1M | ||
| Q2 25 | $7.4B | $342.9M | ||
| Q1 25 | $7.4B | $327.2M | ||
| Q4 24 | $7.5B | $350.9M | ||
| Q3 24 | $7.4B | $389.5M | ||
| Q2 24 | $7.4B | $395.6M |
| Q1 26 | 0.13× | — | ||
| Q4 25 | 0.13× | — | ||
| Q3 25 | 0.22× | — | ||
| Q2 25 | 0.23× | — | ||
| Q1 25 | 0.24× | — | ||
| Q4 24 | 0.29× | — | ||
| Q3 24 | 0.29× | — | ||
| Q2 24 | 0.30× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $74.6M |
| Free Cash FlowOCF − Capex | — | $74.6M |
| FCF MarginFCF / Revenue | — | 156.3% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $97.5M | $74.6M | ||
| Q3 25 | $22.2M | $47.6M | ||
| Q2 25 | $34.3M | $-15.1M | ||
| Q1 25 | $20.4M | $20.0M | ||
| Q4 24 | $90.5M | $15.2M | ||
| Q3 24 | $21.3M | $9.9M | ||
| Q2 24 | $25.9M | $33.5M |
| Q1 26 | — | — | ||
| Q4 25 | $92.3M | $74.6M | ||
| Q3 25 | $21.4M | $47.6M | ||
| Q2 25 | $32.3M | $-15.1M | ||
| Q1 25 | $19.6M | $19.9M | ||
| Q4 24 | $75.4M | — | ||
| Q3 24 | $15.6M | $9.9M | ||
| Q2 24 | $21.3M | $33.4M |
| Q1 26 | — | — | ||
| Q4 25 | 121.0% | 156.3% | ||
| Q3 25 | 28.6% | 39.0% | ||
| Q2 25 | 44.3% | -17.7% | ||
| Q1 25 | 28.4% | 48.4% | ||
| Q4 24 | 129.2% | — | ||
| Q3 24 | 23.5% | 10.8% | ||
| Q2 24 | 33.2% | 35.4% |
| Q1 26 | — | — | ||
| Q4 25 | 6.8% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 2.7% | 0.0% | ||
| Q1 25 | 1.3% | 0.1% | ||
| Q4 24 | 25.8% | 0.0% | ||
| Q3 24 | 8.5% | 0.0% | ||
| Q2 24 | 7.3% | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 4.26× | — | ||
| Q3 25 | 1.20× | 1.19× | ||
| Q2 25 | 1.88× | -0.64× | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 7.98× | 6.74× | ||
| Q3 24 | 1.60× | 2.71× | ||
| Q2 24 | 1.64× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
